Investors in the ABS market are mostly staying on the sidelines waiting for the coronavirus volatility to play itself out. Meanwhile, some investors are focusing solely on AAA-rated assets.

Nonbank Ginnie Mae issuers increased their borrowings under the PTAP program in May but not significantly. Next up: FHA’s forbearance policy on loans in progress.

Taking a close look at the much more stringent capital norms for the GSEs, Matthew Howlett, an equities analyst at Nomura, reiterated his buy rating for Fannie Mae. The hitch? He assumes a ROE of 11.4% by 2024.

If the new rule had been in effect at 3Q19, CRT would have reduced the GSEs’ capital requirement by $22.1 billion. On the other hand, CRT provisions under the 2018 version would have provided $41.3 billion.

Directed by its regulator to curtail non-insurance front-end risk transfer deals, Fannie is piling into CIRTs instead.

The industry wants the SEC to align disclosure norms for publicly registered non-agency MBS with those followed in private placements.

Production of commercial MBS for 2020 is expected to be less what was forecast earlier in the year, according to industry analysts.

The new FHFA-sponsored capital rule is finally here. But how long will it take for Fannie and Freddie to meet the standard before they can be released from conservatorship prison?

A non-QM MBS closed last week and deals from other issuers are in the works. A prime non-agency MBS with newly originated loans was also introduced.

Ginnie Mae is keeping a close eye on the COVID-19 forbearance readings. The wild card: the FHA’s stance on loans in progress.